KFSP8, KFA2-GG-SP(8-11)

General Information


DRACP ID  DRACP04416

Peptide Name   KFSP8, KFA2-GG-SP(8-11)

Sequence  KFAKFAKKFAKFAKGGFGLM

Sequence Length  20

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C110H168N26O21S

Absent amino acids  CDEHINPQRSTVWY

Common amino acids  K

Mass  256185

Pl  11.5

Basic residues  6

Acidic residues  0

Hydrophobic residues  10

Net charge  6

Boman Index  -107

Hydrophobicity  11.5

Aliphatic Index  39.5

Half Life 
  Mammalian: 1.3 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 31953126

Title  Enhanced cell selectivity of hybrid peptides with potential antimicrobial activity and immunomodulatory effect

Doi Not available

Year  2020

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  19643

DRACP is developed by Dr.Zheng's team.